RS
Robert Stein
Founder of MiNK Therapeutics
New York, New York
Overview
Robert Stein is a highly accomplished professional in the biotech and pharma R&D field, currently serving as a Venture Partner at Samsara BioCapital. With a strong background in drug discovery and clinical development, he has held key leadership roles at prominent companies like Agenus, contributing significantly to advancements in oncology and translational medicine.
Stein's career highlights include founding MiNK Therapeutics and serving in various executive positions at Agenus, where he played pivotal roles in R&D, including as President, CSO, and EVP, driving innovative drug development strategies in the pharmaceutical industry.
Work Experience
Venture Partner
2018 - Current
Principal
2008
Creative, collaborative problem solving at the interface or pharmaceutical science, medicine, and business. Over 40 years of experience in leadership in both large pharmaceutical companies and biotech.
Senior R&D Advisor & Founder
2022
MiNK Therapeutics provides Living drugs, Adoptive Cell Therapy, and T Cell Receptors (TCRs).
Raised $5,800,000.00 from GKCC.
Senior Advisor, R&D
2017
President, R&D
2016 - 2017
CSO & EVP, R&D
2014 - 2016
Chief Scientific Officer and Head, R&D
2014 - 2016
Agenus develops and commercializes immunotherapies and vaccines for cancer and infectious diseases.
Raised $366,140,653.00 from Ligand Pharmaceuticals.
Scientific Advisory Board
2020
Joint venture biotech academic incubator as joint venture of Samsara Biocapital, Evotec, and KCK Ltd.
Autobahn Labs is a biotechnology company that accelerates the development of novel therapeutics.
Board Member & CMO
2016
Public Neuroscience Biotechnology Company
Board Member
2020
Board Member
2019
Board Member & Chief Medical Advisor
2018
Scientific Advisory Board Member
2013